Treatment
Medication clinical trials
We’re tracking 7,140 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07041359RecruitingPhase 4
Traditional Chinese medicine for elderly heart disease patients with ongoing symptoms
This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.
Beijing, Beijing MunicipalityAges 75–90 - NCT07034079RecruitingPhase 2
Adding ridges to dentures for better fit and comfort
This study tests adding small ridges (called palatal rugae) to a complete upper denture to see if it makes patients more satisfied and improves their quality of life related to oral health. It may help dentures feel more natural and stable.
Islamabad, IslamabadAges 40–80 - NCT07036731Recruiting
Urine test study for second bladder surgery
This trial compares the need for a second surgery for people with early-stage bladder cancer. It uses a simple urine test to see if the test can help decide whether a second operation is necessary, which could save some patients from an extra procedure.
Nanjing, JiangsuAges 18–80 - NCT07034742RecruitingEarly Phase 1
MRD testing after stomach cancer surgery
This study looks at whether a blood test for leftover cancer cells (called MRD) after stomach cancer surgery can help guide treatment. It is for people with a certain type of stomach cancer that has spread to nearby tissues but not to distant organs, and who are having surgery as their first treatment.
BeijingAges 18–75 - NCT07035847Recruiting
Transaxillary TAVR guided by ultrasound only
This trial is testing a new way to replace your aortic valve using a small tube through your armpit, guided only by ultrasound (echocardiography) instead of X-rays. It may be an option if you have severe aortic stenosis and are a good fit for this less invasive approach.
Beijing, Beijing MunicipalityAges Any age - NCT07043270RecruitingPhase 2
Alternating chemo regimens for borderline resectable pancreatic cancer
This trial compares two chemotherapy regimens — GnP (gemcitabine and nab-paclitaxel) and mFOLFIRINOX — given in alternating cycles for people with borderline resectable pancreatic cancer. The goal is to see if this alternating approach can shrink the tumor enough to allow surgery.
Lebanon, New HampshireAges 18 years+ - NCT07041229Enrolling by invitation
Comparing two ways to remove large colon polyps
This trial is for people with large (20-60 mm), non-cancerous colon growths on a wide base. It compares two endoscopic removal methods—ESD and EMR—to see which works best.
MoscowAges 18–100 - NCT07041255Recruiting
Cold vs. Hot Loop Snare for Medium Colon Polyps
This trial compares two techniques (cold vs. hot loop snare) to remove medium-sized, non-cancerous colon polyps. It aims to find which method is safer and more effective for polyps that are 10–14 mm and flat or slightly raised.
MoscowAges 18–100 - NCT07041450Recruiting
Screening for Alzheimer's treatment using digital tests and blood tests
This study is testing whether simple digital memory tests and blood tests can help find people who might qualify for anti-amyloid treatments (medications that target Alzheimer's-related proteins). It aims to make screening easier and faster, without needing a spinal tap or PET scan.
Greenfield Park, QuebecAges 55–90 - NCT07039591RecruitingEarly Phase 1
Testing a vaginal ring for comfort and use in healthy women
This study tests a non-medicated vaginal ring to see if women find it comfortable and easy to use. If you are a healthy, sexually active woman using non-vaginal birth control, you may be eligible.
Atlanta, GeorgiaAges 18–49 - NCT07039734Recruiting
Ovarian reserve in Fragile X premutation carriers
This study looks at egg supply (ovarian reserve) in women who carry the Fragile X premutation. It aims to understand fertility potential better and help guide future family planning.
Paris, FranceAges 18–40 - NCT07036952Enrolling by invitation
Omega-3 for metabolic syndrome in PCOS
This trial tests if adding omega-3 supplements to standard care helps women with PCOS who also have metabolic syndrome. It may offer a natural way to improve associated health issues.
Dhaka, BsmmuAges 18–36 - NCT07036588Recruiting
Drain tube study to prevent leaks after rectal cancer surgery
This study tests whether using a special drain tube during rectal cancer surgery helps prevent leakage at the connection point where the intestine is rejoined. If you are planning to have surgery to remove rectal cancer, this might lower your risk of complications.
Yuzhong, Chongqing MunicipalityAges 18–80 - NCT07034443Recruiting
Magnetic stimulation for leaky bowel after J-pouch surgery
This trial tests if high-intensity focused electromagnetic stimulation can improve bowel control in people who have a J-pouch after ulcerative colitis surgery. It may help if you have leakage or incontinence.
Los Angeles, CaliforniaAges 18 years+ - NCT07038213Enrolling by invitation
Study of kidney protection in type 2 diabetes
This study looks at how genes may affect kidney disease in people with type 2 diabetes. It tests treatments to protect the kidneys. If you are of Kazakh ethnicity and have type 2 diabetes, you may be able to join.
AstanaAges 18–65 - NCT07041034Recruiting
Managing behavioral symptoms in dementia at long-term care
This trial tests a new approach to help manage behavioral and psychological symptoms of dementia (BPSD) for people living in long-term care facilities. It aims to improve care and quality of life for residents with dementia.
New Taipei CityAges 65–110 - NCT07037563Recruiting
AI chatbot for managing diabetes, blood pressure, or cholesterol
This trial is testing a new AI chatbot that helps people in Hong Kong manage their health conditions like high blood sugar, high blood pressure, or high cholesterol. If you take medication for one of these conditions or care for someone who does, you may be able to join.
Hong KongAges 18 years+ - NCT07034391RecruitingPhase 2
PD-1 inhibitor with denosumab and chemo for advanced lung cancer
This trial tests a combination of an immunotherapy drug (PD-1 inhibitor), a bone-strengthening drug (denosumab), and chemotherapy for people with advanced or spread non-squamous non-small cell lung cancer that does not have certain genetic changes. The goal is to see if this combination helps shrink tumors and control the disease.
Shenyang, LiaoningAges 18–75 - NCT07041268RecruitingPhase 2
Rituximab for recent type 1 diabetes in teens
This trial tests if repeated infusions of rituximab (a drug that calms the immune system) can help preserve insulin production in adolescents newly diagnosed with type 1 diabetes. It is for teens in Russia who started diabetes treatment within the last 4 months.
MoscowAges 12–18 - NCT07035535Enrolling by invitation
Using genetic tests to predict antibiotic resistance in lung infections
This trial looks at whether a special genetic test (tNGS) can predict which antibiotics will work for bacteria causing lung infections. It may help doctors choose the right treatment faster.
Nanjing, JiangsuAges 18 years+ - NCT07040098RecruitingPhase 2
Optimizing immunotherapy with chemo-radiation for rectal cancer
This trial tests combining immunotherapy with standard chemotherapy and radiation before surgery for locally advanced rectal cancer. It aims to see if this approach can improve outcomes for patients whose tumors have certain genetic features (pMMR or MSS).
BeijingAges 18–75 - NCT07038304RecruitingPhase 2
Radiation for cancer growth in prostate cancer that stopped responding to hormones
This trial tests whether giving precise radiation to a few spots of cancer growth can help control prostate cancer that has stopped responding to hormone therapy. It is for people with up to 3 growing or new spots of cancer on a special scan.
GroningenAges 18 years+ - NCT07039292Enrolling by invitation
Can e-cigarettes help reduce smoking?
This study tests whether e-cigarettes can help people who smoke but have not wanted to use other treatments. If you currently smoke and have declined traditional options like nicotine patches or quitlines, you may be able to join.
Charleston, South CarolinaAges 21 years+ - NCT07040592RecruitingPhase 2
Semaglutide for HIV and alcohol use
This study is testing whether semaglutide, a medication already used for diabetes and weight loss, can help people with HIV who also have an alcohol use disorder cut back on drinking. It is for patients treated at the Atlanta VA Healthcare System.
Decatur, GeorgiaAges 18–99
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,140 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.